Physician profile
Todd E Blattman
NPI 1295709319
$6,297.99
in general payments reported to CMS, 2019-2025
36 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $385 · 2021: $1,757 · 2022: $183 · 2023: $330 · 2024: $763 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,121 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,121.28 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,304.86 | 2021 | |
| Novo Nordisk INC | $1,192.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $543.82 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Phathom Pharmaceuticals, INC. | $499.44 | 2024-2025 | Voquezna |
| Pfizer INC. | $407.96 | 2019-2025 | |
| Glaxosmithkline, LLC. | $290.19 | 2019-2025 | Arexvy |
| Merck Sharp & Dohme LLC | $170.40 | 2019-2024 | Capvaxive, Vaxneuvance, Gardasil 9 |
| Intuitive Surgical, INC. | $158.11 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $142.48 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $134.66 | 2019-2024 | Trintellix |
| Inspire Medical Systems, INC. | $130.15 | 2023 | Inspire |
| Esperion Therapeutics, INC. | $110.02 | 2021 | |
| Lilly USA, LLC | $96.45 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $95.64 | 2021-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Amgen INC. | $94.03 | 2019 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Blattman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.